d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis

Status Completed

Clinical Trial Summary

The Researchers are trying to determine if 68Ga-DOTATATE PET/CT imaging will have a similar accuracy as 18FDG PET/CT in diagnosing cardiac sarcoidosis and if it will be able to do so without the need for complex patient dietary preparation that is required with 18FDG PET/CT.

Clinical Trial Description

Prospective study of 15 consecutive patients with suspected or newly diagnosed cardiac sarcoidosis (CS) who are referred for a clinically indicated 18FDG (and 13NH3) PET/CT scan for cardiac sarcoidosis (CS) will be approached to undergo a 68Ga-DOTATATE PET/CT scan. Comparison will then be made between the 68Ga-DOTATATE PET/CT and the 18FDG and 13NH3 PET/CT to determine if 68Ga-DOTATATE detects CS. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03549598
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	Phase 4
Start date	July 20, 2018
Completion date	October 2, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03705884` - PET/MR Imaging In Patients With Cardiac Sarcoidosis	N/A
Recruiting	`NCT04017936` - Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis	Phase 2
Recruiting	`NCT06131112` - Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis
Terminated	`NCT03923049` - Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis	N/A
Not yet recruiting	`NCT05954507` - Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis	N/A
Recruiting	`NCT04737317` - Diagnostic Criteria in Cardiac Sarcoidosis
Recruiting	`NCT06409585` - Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Recruiting	`NCT03057002` - UTSW HP [13-C] Pyruvate Injection in HCM
Completed	`NCT03599414` - CASPA: CArdiac Sarcoidosis in PApworth
Withdrawn	`NCT02812849` - Somatostatin Receptor Imaging in Cardiac Sarcoidosis
Completed	`NCT01729169` - Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET	N/A
Recruiting	`NCT04758650` - Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis	Phase 2
Recruiting	`NCT04206163` - Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis	N/A
Recruiting	`NCT05499637` - [68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation	Phase 2
Recruiting	`NCT03593759` - Cardiac Sarcoidosis Randomized Trial	Phase 3
Recruiting	`NCT05145023` - Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis
Enrolling by invitation	`NCT04774549` - Inflammatory Cardiomyopathy Bern Registry
Recruiting	`NCT03049254` - Mayo AVC Registry and Biobank
Completed	`NCT03746847` - PET Imaging in Patients With Suspected Cardiac Sarcoidosis
Recruiting	`NCT01477359` - Cardiac Sarcoidosis Multi-Center Prospective Cohort